1-2 of 2
Daniel Zelterman, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Use of Hypomethylating Agents (HMAs) in Patients with Relapsed and Refractory Acute Myeloid Leukemia (RR-AML): Clinical Outcomes and Their Predictors in a Large International Patient Cohort

Maximilian Stahl, MD, Nikolai A Podoltsev, MD PhD, Michelle DeVeaux, Sarah Perreault, Pharm.D., BCPS, BCOP, Raphaël Itzykson, MD PhD, Ellen K. Ritchie, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Rami S. Komrokji, MD, Vijaya R. Bhatt, MD, Aref Al-Kali, MD, Thomas Cluzeau, Valeria Santini, MD, Andrew Brunner, MD, Gail J. Roboz, Pierre Fenaux, MD PhD, Mark Litzow, MD, Norbert Vey, Vivek Verma, MD, Ulrich Germing, M. D., Pau Montesinos Fernández, MD, Daniel Zelterman, PhD, Tae Kon Kim, MD PhD, Thomas Prebet, MD PhD, Steven D Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2016) 128 (22): 1063.
https://doi.org/10.1182/blood.V128.22.1063.1063
Published: 2016
Journal Articles

Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Andrew R Branagan, MD, Eamon Duffy, Terri L Parker, MD, Stuart Seropian, MD, Connor Foster, Lin Zhang, Rakesh Verma, PhD(MDcal Oncology), MBA, MS, BCA, BS, Daniel Zelterman, PhD, Geliang Gan, PhD, Debra S. Brandt, DO, Jeremy Kortmansky, David H Witt, MD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD
Journal: Blood
Blood (2016) 128 (22): 2139.
https://doi.org/10.1182/blood.V128.22.2139.2139
Published: 2016